Cyclacel Pharmaceuticals DPO Ratio | CYCCP

Annual DPO Ratio Cyclacel Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
1.79 K	1.79 K	1.79 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
I-Mab IMAB	4.85 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Qilian International Holding Group Limited QLI	61.7	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	47.4	-	1.35 %	$ 17.8 M	China
Завод ДИОД DIOD	30.3	-	-	-	Russia
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	85.8	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	163	$ 3.78	1.89 %	$ 911 M	USA
Affimed N.V. AFMD	2.52 K	-	-34.95 %	$ 21.5 M	Germany
Arcutis Biotherapeutics ARQT	133	$ 23.9	1.01 %	$ 3.04 B	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	238	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Axsome Therapeutics AXSM	529	$ 206.68	0.16 %	$ 10.3 B	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	245	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	355	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
ChromaDex Corporation CDXC	76.3	-	-0.88 %	$ 598 M	USA